These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3677422)

  • 41. [Erythrocyte levels of urosynthetase in various types and grades of liver disease].
    Sánchez Rodríguez A; Pérez Sandoval D; Cruz Hernández JJ; Rico Sánchez J; Juanes González A
    Rev Clin Esp; 1983 Jan; 168(1):51-4. PubMed ID: 6844680
    [No Abstract]   [Full Text] [Related]  

  • 42. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute intermittent porphyria: uroporphyrinogen-I-synthetase activity in erythrocytes as a diagnostic index].
    Formgren B; Wetterberg L
    Lakartidningen; 1978 May; 75(19):1921-4. PubMed ID: 651454
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The spectrophotometric determination of uroporphyrinogen I synthetase activity.
    Grandchamp B; Phung N; Grelier M; Nordmann Y
    Clin Chim Acta; 1976 Jul; 70(1):113-8. PubMed ID: 947611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uroporphyrinogen synthetase in erythrocytes. Its diagnostic value in latent acute intermittent porphyria with special regard to the gene penetrance.
    With TK; Pedersen JS
    Dan Med Bull; 1981 Mar; 28(1):27-34. PubMed ID: 7238130
    [No Abstract]   [Full Text] [Related]  

  • 48. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer.
    Leibovici L; Schoenfeld N; Yehoshua HA; Mamet R; Rakowsky E; Shindel A; Atsmon A
    Cancer; 1988 Dec; 62(11):2297-300. PubMed ID: 3179945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnosis of acute intermittent porphyria on the basis of uroporphyrinogen I synthase activity in the erythrocytes; comparison of 2 methods].
    Kostrzewska E; Gregor A; Traczyk A; Rudowski W
    Pol Tyg Lek; 1979 Aug; 34(33):1305-7. PubMed ID: 514844
    [No Abstract]   [Full Text] [Related]  

  • 50. [Letter: Determination of uroporphyrinogen I synthetase in intermittent acute porphyria. 7 cases].
    Koehl C; Abecassis J; Wertenschlag J
    Nouv Presse Med; 1975 Nov; 4(38):2735. PubMed ID: 1202467
    [No Abstract]   [Full Text] [Related]  

  • 51. Erythrocyte uroporphyrinogen synthase activity as a possible diagnostic aid in the diagnosis of lymphoproliferative diseases.
    Epstein O; Lahav M; Schoenfeld N; Nemesh L; Shaklai M; Atsmon A
    Cancer; 1983 Sep; 52(5):828-32. PubMed ID: 6871824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Family studies on the activity of uroporphyrinogen I synthase in diagnosis of acute intermittent porphyria.
    Astrup EG
    Clin Sci Mol Med; 1978 Mar; 54(3):251-6. PubMed ID: 630801
    [No Abstract]   [Full Text] [Related]  

  • 53. Reconstitution of apo-porphobilinogen deaminase: structural changes induced by cofactor binding.
    Scott AI; Clemens KR; Stolowich NJ; Santander PJ; Gonzalez MD; Roessner CA
    FEBS Lett; 1989 Jan; 242(2):319-24. PubMed ID: 2644132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-cost uroporphyrinogen I synthase screening for acute intermittent porphyria.
    Brocklehurst D
    Clin Chem; 1978 Apr; 24(4):730-1. PubMed ID: 639289
    [No Abstract]   [Full Text] [Related]  

  • 55. Experience with the red cell uroporphyrinogen synthase (URO-S) assay in kindreds with acute intermittent porphyria (AIP).
    Kreimer-Birnbaum M; Bonkowsky HL; Bottomley SS
    Int J Biochem; 1980; 12(5-6):807-10. PubMed ID: 7450137
    [No Abstract]   [Full Text] [Related]  

  • 56. Uroporphyrinogen I synthase from human erythrocytes: separation, purification, and properties of isoenzymes.
    Miyagi K; Kaneshima M; Kawakami J; Nakada F; Petryka ZJ; Watson CJ
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6172-6. PubMed ID: 42911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland.
    Mustajoki P; Desnick RJ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6494):505-9. PubMed ID: 3928029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple method for measuring erythrocyte porphobilinogenase, and its use in the diagnosis of acute intermittent porphyria.
    Batlle AM; Wider de Xifra EA; Stella AM
    Int J Biochem; 1978; 9(12):871-5. PubMed ID: 33845
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of lead on the activity of erythrocyte porphobilinogen deaminase in vivo and in vitro.
    Tomokuni K; Ichiba M
    Toxicol Lett; 1990 Feb; 50(2-3):137-42. PubMed ID: 2309232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conjugated effect of light and uroporphyrin on porphobilinogen.
    Nordmann Y; Grandchamp B
    Biochem Med; 1976 Apr; 15(2):119-25. PubMed ID: 962896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.